Articles written by Melissa A. Kreso
Phasing Out Desflurane at Three New York State Institutions
Over the past decade, there has been movement towards eliminating desflurane usage both nationally and internationally, with Scotland, England, and the Canadian province of Newfoundland and Labrador officially phasing out the agent. This article chronicles the journey of three institutions in New York State as they phased out desflurane from their formularies—and provides guidance to other NYS hospitals looking to do the same.
Read the articleNew ASA Guidelines for Neuromuscular Blockade: Contraceptive Considerations
Since obtaining FDA approval in 2015, the steroidal encapsulating agent sugammadex has become anesthesia providers’ neuromuscular blockade (NMB) reversal agent of choice.
Read the article




